Akthelia Pharmaceuticals
PrivateLast Round
Grant
Oct 17, 2024
Total Funding Raised
$200,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Akthelia Pharmaceuticals is a biopharmaceutical company that develops small molecule therapeutics designed to enhance the body's innate immune defense mechanisms to treat mucosal and epithelial barrier-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Akthelia Pharmaceuticals Comparables
Compare Akthelia Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Promakhos Therapeutics | 78% | |
| Enzychem Lifesciences | 75% | |
| EpicentRx | 71% | |
Akthelia Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 17, 2024 | ||||
| Grant | Apr 17, 2023 | ||||
| Pre Seed | Jan 1, 2022 | ||||
| Pre Seed | Dec 31, 2021 |
Key People
Founding team and executive leadership
Akthelia Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rannís - The Icelandic Centre for Research | Grant |
| NSA Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 1133% MoM, from 43 to 530.
- Mar 1, 2026
Monthly visitors grew 150% MoM.
Akthelia Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Akthelia Pharmaceuticals's valuation, stock price, and market status.